Houlihan Financial Resource Group’s Gilead Sciences GILD Stock Holding History

Houlihan Financial Resource Group’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	$12K	Buy	+200	New	+$13.9K	0.01%	268

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Houlihan Financial Resource Group's GILD Position: Q3 2020 in Review

Houlihan Financial Resource Group opened a new position in Gilead Sciences (GILD) in Q3 2020: 200 shares worth $12K. The stake represents 0.01% of the portfolio and ranks #268 among its holdings.

1,538 funds tracked by Wall St. Rank hold GILD as of Q3 2020.

Houlihan Financial Resource Group held 200 shares of Gilead Sciences worth $12K as of Q3 2020.
Gilead Sciences was a new Houlihan Financial Resource Group position in Q3 2020.
Gilead Sciences made up 0.01% of Houlihan Financial Resource Group's portfolio in Q3 2020, its #268 holding.
1,538 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2020.

Based on Houlihan Financial Resource Group's 13F filing for Q3 2020, filed 13 Nov 2020.